Search results
Results from the WOW.Com Content Network
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers.
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
In 2016, Musk launched Neuralink with help from seven scientists and one engineer. Only two remain of the founding group—Musk and engineer DJ Seo. The goal of Neuralink is to develop brain ...
He is the chief executive officer of neurotechnology company Neuralink and the wealth manager of billionaire entrepreneur Elon Musk since 2016. As Musk's adviser, right-hand man, and fixer, Birchall holds executive or administrative positions in other endeavors of his including the Boring Company, Musk Foundation, xAI, and managing his family ...
Elon Musk’s Neuralink has attached a computer to someone’s brain, he has said. Neuralink hopes to build a brain-computer interface that can be implanted in humans. Now Mr Musk says the system ...
The company made the announcement on Twitter Thursday evening but has provided no details about a potential study, which was not listed on the U.S. government database of clinical trials.
Rapoport was previously on the eight-member founding team at Elon Musk’s brain–computer interface company, Neuralink. Rapoport left Neuralink in 2018. [1] Rapoport, along with Michael Mager, an investor and business builder, and a team of experts in areas such as neuroscience, microfabrication and software launched Precision Neuroscience in ...
Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.